Analysis of a Biomarker Signature in Patients With Multiple Sclerosis (MS) Treated With Gilenya (FTY720)
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Trial of BKM120/Tamoxifen-combination in Patients With HR-pos, HER2-neg Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Study of PDR001 in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety, Tolerability, and Efficacy Study of LFX453 in Actinic Keratosis Patients
- Status
- COMPLETED
- Phase
- PHASE2
Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A in Naive Aplastic Anemia (AA) Subjects
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Renal Function
- Status
- COMPLETED
- Phase
- PHASE1
Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIA
- Status
- COMPLETED
- Phase
- PHASE3
A 24-week, Multicenter, proSpective stUdy to Evaluate the PASI 90 Clinical Response Rate and the Safety PRofile of sEcukinuMab 300 mg in Cw6-negativE and Cw6-positive Patients With Moderate to Severe Chronic Plaque-type Psoriasis (SUPREME)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Safety and Efficacy of Ceritinib in Combination With Nivolumab in Patients With ALK-positive Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF)
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Evaluation of Hepatic Function Impairment on the Pharmacokinetics of LEE011
- Status
- COMPLETED
- Phase
- PHASE1
CINC424A2X01B Rollover Protocol
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
BYL719 and Nab-Paclitaxel in Locally Recurrent or Metastatic HER-2 Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluation of Oral Care to Prevent Oral Mucositis in ER Positive MBC Patients Treated With Everolimus: Phase 3 RCT
- Status
- COMPLETED
- Phase
- PHASE3
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
- Status
- COMPLETED
- Phase
- PHASE3
PCA062 in pCAD-positive Tumors.
- Status
- COMPLETED
- Phase
- PHASE1
Fingolimod Effect on Cytokine and Chemokine Levels
- Status
- COMPLETED
- Phase
- PHASE4
A Phase 1 Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Hepatic Function
- Status
- COMPLETED
- Phase
- PHASE1